Ciltacabtagene Autoleucel for Patients With Triple-class Exposed Multiple Myeloma: Adjusted Comparison of CARTITUDE-1 Patient Outcomes Versus Real-world Clinical Practice
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-12-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/HS9.0000000000000813 |
| _version_ | 1797283909595037696 |
|---|---|
| author | Michel Delforge Marie-Christiane Vekemans Julien Depaus Nathalie Meuleman Ann Van de Velde Isabelle Vande Broek Sophie Vandervennet Sandra Van Hoorenbeeck Evelien Moorkens Danielle Strens Joris Diels Francesca Ghilotti Benjamin Haefliger Sander Dalhuisen William Deraedt Sébastien Anguille |
| author_facet | Michel Delforge Marie-Christiane Vekemans Julien Depaus Nathalie Meuleman Ann Van de Velde Isabelle Vande Broek Sophie Vandervennet Sandra Van Hoorenbeeck Evelien Moorkens Danielle Strens Joris Diels Francesca Ghilotti Benjamin Haefliger Sander Dalhuisen William Deraedt Sébastien Anguille |
| author_sort | Michel Delforge |
| collection | DOAJ |
| first_indexed | 2024-03-07T17:38:37Z |
| format | Article |
| id | doaj.art-17207826678541428346ed53dedf3abe |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T17:38:37Z |
| publishDate | 2022-12-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-17207826678541428346ed53dedf3abe2024-03-02T16:11:58ZengWileyHemaSphere2572-92412022-12-01612e81310.1097/HS9.0000000000000813202212000-00009Ciltacabtagene Autoleucel for Patients With Triple-class Exposed Multiple Myeloma: Adjusted Comparison of CARTITUDE-1 Patient Outcomes Versus Real-world Clinical PracticeMichel Delforge0Marie-Christiane Vekemans1Julien Depaus2Nathalie Meuleman3Ann Van de Velde4Isabelle Vande Broek5Sophie Vandervennet6Sandra Van Hoorenbeeck7Evelien Moorkens8Danielle Strens9Joris Diels10Francesca Ghilotti11Benjamin Haefliger12Sander Dalhuisen13William Deraedt14Sébastien Anguille151 Universitaire Ziekenhuizen Leuven, Belgium2 Cliniques Universitaires Saint-Luc, Brussels, Belgium3 Department of Haematology, Université catholique de Louvain, CHU UCL Namur, Yvoir, Belgium4 Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium5 Division of Hematology and Center for Cell Therapy & Regenerative Medicine, Antwerp University Hospital, Edegem, Belgium7 AZ Nikolaas, Haematology, Sint-Niklaas, Belgium8 Janssen-Cilag NV, Beerse, Belgium8 Janssen-Cilag NV, Beerse, Belgium8 Janssen-Cilag NV, Beerse, Belgium9 Realidad bvba, Grimbergen, Belgium10 Janssen Pharmaceutica NV, Beerse, Belgium11 Janssen-Cilag SpA, Cologno Monzese, Italy12 Cilag GmbH International, Zug, Switzerland13 Janssen-Cilag BV, Breda, the Netherlands10 Janssen Pharmaceutica NV, Beerse, Belgium5 Division of Hematology and Center for Cell Therapy & Regenerative Medicine, Antwerp University Hospital, Edegem, Belgiumhttp://journals.lww.com/10.1097/HS9.0000000000000813 |
| spellingShingle | Michel Delforge Marie-Christiane Vekemans Julien Depaus Nathalie Meuleman Ann Van de Velde Isabelle Vande Broek Sophie Vandervennet Sandra Van Hoorenbeeck Evelien Moorkens Danielle Strens Joris Diels Francesca Ghilotti Benjamin Haefliger Sander Dalhuisen William Deraedt Sébastien Anguille Ciltacabtagene Autoleucel for Patients With Triple-class Exposed Multiple Myeloma: Adjusted Comparison of CARTITUDE-1 Patient Outcomes Versus Real-world Clinical Practice HemaSphere |
| title | Ciltacabtagene Autoleucel for Patients With Triple-class Exposed Multiple Myeloma: Adjusted Comparison of CARTITUDE-1 Patient Outcomes Versus Real-world Clinical Practice |
| title_full | Ciltacabtagene Autoleucel for Patients With Triple-class Exposed Multiple Myeloma: Adjusted Comparison of CARTITUDE-1 Patient Outcomes Versus Real-world Clinical Practice |
| title_fullStr | Ciltacabtagene Autoleucel for Patients With Triple-class Exposed Multiple Myeloma: Adjusted Comparison of CARTITUDE-1 Patient Outcomes Versus Real-world Clinical Practice |
| title_full_unstemmed | Ciltacabtagene Autoleucel for Patients With Triple-class Exposed Multiple Myeloma: Adjusted Comparison of CARTITUDE-1 Patient Outcomes Versus Real-world Clinical Practice |
| title_short | Ciltacabtagene Autoleucel for Patients With Triple-class Exposed Multiple Myeloma: Adjusted Comparison of CARTITUDE-1 Patient Outcomes Versus Real-world Clinical Practice |
| title_sort | ciltacabtagene autoleucel for patients with triple class exposed multiple myeloma adjusted comparison of cartitude 1 patient outcomes versus real world clinical practice |
| url | http://journals.lww.com/10.1097/HS9.0000000000000813 |
| work_keys_str_mv | AT micheldelforge ciltacabtageneautoleucelforpatientswithtripleclassexposedmultiplemyelomaadjustedcomparisonofcartitude1patientoutcomesversusrealworldclinicalpractice AT mariechristianevekemans ciltacabtageneautoleucelforpatientswithtripleclassexposedmultiplemyelomaadjustedcomparisonofcartitude1patientoutcomesversusrealworldclinicalpractice AT juliendepaus ciltacabtageneautoleucelforpatientswithtripleclassexposedmultiplemyelomaadjustedcomparisonofcartitude1patientoutcomesversusrealworldclinicalpractice AT nathaliemeuleman ciltacabtageneautoleucelforpatientswithtripleclassexposedmultiplemyelomaadjustedcomparisonofcartitude1patientoutcomesversusrealworldclinicalpractice AT annvandevelde ciltacabtageneautoleucelforpatientswithtripleclassexposedmultiplemyelomaadjustedcomparisonofcartitude1patientoutcomesversusrealworldclinicalpractice AT isabellevandebroek ciltacabtageneautoleucelforpatientswithtripleclassexposedmultiplemyelomaadjustedcomparisonofcartitude1patientoutcomesversusrealworldclinicalpractice AT sophievandervennet ciltacabtageneautoleucelforpatientswithtripleclassexposedmultiplemyelomaadjustedcomparisonofcartitude1patientoutcomesversusrealworldclinicalpractice AT sandravanhoorenbeeck ciltacabtageneautoleucelforpatientswithtripleclassexposedmultiplemyelomaadjustedcomparisonofcartitude1patientoutcomesversusrealworldclinicalpractice AT evelienmoorkens ciltacabtageneautoleucelforpatientswithtripleclassexposedmultiplemyelomaadjustedcomparisonofcartitude1patientoutcomesversusrealworldclinicalpractice AT daniellestrens ciltacabtageneautoleucelforpatientswithtripleclassexposedmultiplemyelomaadjustedcomparisonofcartitude1patientoutcomesversusrealworldclinicalpractice AT jorisdiels ciltacabtageneautoleucelforpatientswithtripleclassexposedmultiplemyelomaadjustedcomparisonofcartitude1patientoutcomesversusrealworldclinicalpractice AT francescaghilotti ciltacabtageneautoleucelforpatientswithtripleclassexposedmultiplemyelomaadjustedcomparisonofcartitude1patientoutcomesversusrealworldclinicalpractice AT benjaminhaefliger ciltacabtageneautoleucelforpatientswithtripleclassexposedmultiplemyelomaadjustedcomparisonofcartitude1patientoutcomesversusrealworldclinicalpractice AT sanderdalhuisen ciltacabtageneautoleucelforpatientswithtripleclassexposedmultiplemyelomaadjustedcomparisonofcartitude1patientoutcomesversusrealworldclinicalpractice AT williamderaedt ciltacabtageneautoleucelforpatientswithtripleclassexposedmultiplemyelomaadjustedcomparisonofcartitude1patientoutcomesversusrealworldclinicalpractice AT sebastienanguille ciltacabtageneautoleucelforpatientswithtripleclassexposedmultiplemyelomaadjustedcomparisonofcartitude1patientoutcomesversusrealworldclinicalpractice |